text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 144598-75-4 | Product Number: P1897

Paliperidone


Purity: >97.0%(T)
Synonyms:
  • 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
Documents:
200MG
€62.00
1   5  
1G
€216.00
2   Contact Us

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Product Number P1897
Purity / Analysis Method >97.0%(T)
Molecular Formula / Molecular Weight C__2__3H__2__7FN__4O__3 = 426.49  
Physical State (20 deg.C) Solid
CAS RN 144598-75-4
Reaxys Registry Number 8808385
PubChem Substance ID 125307525
SDBS (AIST Spectral DB) 52833
Specifications
Appearance Light orange to Yellow to Green powder to crystal
Purity(HPLC) min. 95.0 area%
Purity(Nonaqueous Titration) min. 97.0 %
Properties (reference)
GHS
Pictogram Pictogram
Signal Word Danger
Hazard Statements H301 : Toxic if swallowed.
Precautionary Statements P501 : Dispose of contents/ container to an approved waste disposal plant.
P270 : Do not eat, drink or smoke when using this product.
P264 : Wash skin thoroughly after handling.
P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth.
P405 : Store locked up.
Related Laws:
RTECS# UV1164720
Transport Information:
UN Number UN2811
Class 6.1
Packing Group III
HS Number 2934999090
Application
Paliperidone (9-Hydroxyrisperidone): A dopamine D2 and Serotonin 5-HT2 Receptors Antagonist

Paliperidone (another name: 9-hydroxyrisperidone), a benzisoxazole derivative, is acts as a dopamine type 2 (D2) and serotonin type 2 (5-HT2) receptors antagonist, and the major active metabolite of risperidone [R0087]. Similarly to risperidone, paliperidone has also affinity for α1- and α2-adrenergic, and H1 histaminergic receptors. Paliperidone has no affinity for cholinergic muscarinic or β1- and β2-adrenergic receptors. The pharmacological activity of the (+)- and (-)-paliperidone enantiomers is qualitatively and quantitatively similar in vitro. Risperidone is used as an antipsychotic agent with relatively few side effects. Recently, paliperidone extended-release formulation is developed for clinical use. (The product is for research purpose only.)

References


PubMed Literature


TCIMAIL
Documents
Safety Data Sheet (SDS) Search
Please select Language.

The requested SDS is not available.

• Please check that the Product Number you have entered is correct.

• If your information is correct and you are still not able to view the requested SDS,  please Contact Us for more information.

C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number is entered
Other Documents